Guinandam, Kenvirly H.
HRN: 25-74-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2024
AMPICILLIN 1GM (VIAL)
08/26/2024
09/02/2024
IVTT
2g
Q6 ANST
PROM X 7 Hours; Ruptured BOW
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes